Fastest
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →https://www.patsnap.com/resources/blog/rd-blog/neurostimulation-device-wireless-telemetry-patent-landscape-patent-landscape/ · Patsnap · data cut-off 2026-08-31 · downloaded from the live page
Patent Landscape · Medical Devices & ImplantsNeurostimulation device wireless telemetry patents: who leads and where the filing gaps sit
A data-backed look at wireless telemetry patents for neurostimulation devices: who leads filing, how concentrated the field is, and where technology composition points to open ground.
564
Published Records
79%
Top-5 Share of All Records
+29%
Filing Growth 2021→2024
US
Leading Jurisdiction
Filing growth = 2021 (7 records) → 2024 (9); 2024 is the last year we treat as complete. Top-5 share = the 5 largest assignees ÷ all 564 records in scope (CR5), not the ranked leaders only.
Published byPatsnap Research··6 min readSourced from Patsnap Eureka
Overview
What this landscape covers
Wireless telemetry for neurostimulation devices sits at the intersection of implantable electrotherapy and short-range radio engineering. The dataset behind this page pulls 564 published records filed between 2015 and mid-2026 across the IPC classes that define this space: A61N for electrotherapy and radiation therapy, A61B for diagnosis and surgery, and the wireless-communications classes H04W, H04L and H04B. Records must reference both a neurostimulation device and a telemetry or wireless-transceiver mechanism to qualify.
The record set skews heavily toward implantable stimulation platforms rather than external wearables, and toward the receiving offices where implantable device makers file first: the United States, Europe and the WIPO PCT route. That filing pattern, together with the assignee concentration below, frames who actually controls claim space in this niche and where a new entrant might still find room.
Filing activity and technology composition, 2015-2026
Source: Patsnap Eureka. Assignee ranking and totals. Derived from a Patsnap search on Neurostimulation Device Wireless Telemetry Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
The data
Filing trend and technology composition
Two views of the same 564-record set: how filing activity has moved year over year, and which IPC subclasses carry the claim volume. Both use the full record count as denominator, so class shares add up to more than 100% because a single record can carry several classes.
Filing activity, 2017-2026
Annual filings rose from 7 in 2017 to a peak of 12 in 2020, then held in a narrower band; the 2021-to-2024 span shows +29% growth, the most recent period reliable enough to read as a trend given the roughly 18-month lag between filing and publication. Years after 2024 will fill in as publications catch up and should not yet be read as a slowdown.
Publication lags filing by roughly 18 months, so 2025 onwards are still filling in. Growth rates on this page therefore end at 2024; running them to the last bar would understate the field.
Technology composition by IPC subclass
A61N electrotherapy claims dominate the set at 97.2% of the 564 records, which is expected given the search scope. The more informative signal sits lower down: A61B diagnosis/surgery crossover reaches 12.4%, data-processing classes G06F and G16H sit at 8.2% and 6.0%, and the radio-specific classes H04B and H01Q cover only 2.7% and 1.4% respectively — a thin footprint for a field defined by wireless transmission.
Shares are the percentage of the 564 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Source: Patsnap Eureka. Filing trend and technology composition. Derived from a Patsnap search on Neurostimulation Device Wireless Telemetry Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.
Go deeper on Neurostimulation Device Wireless Telemetry Patent Landscape with Eureka
This page is one run against one query. Ask Eureka your own question about neurostimulation device wireless telemetry patent landscape and every answer comes back with the patent numbers behind it.
Try EurekaKey patents
Representative filing and most-cited prior art
Representative filing
System for programming a neurostimulation device with seamless integration programming modes (AU2012352009B2)
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
A system and method for programming a neurostimulation device coupled to a plurality of implanted electrodes. A first electrode configuration corresponding to a first programming mode is defined; a second, different programming mode is selected; a second electrode configuration is derived from the first in response to that selection; and the device is then programmed under the second mode.Filed by Boston Scientific Neuromodulation Corporation, 2015-05-07.
View full filingMost-cited records in this landscape
| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | US6308102B1 | Patient interactive neurostimulation system and method | 431 |
| 2 | US7167743B2 | Collecting activity information to evaluate therapy | 339 |
| 3 | US20090149917A1 | Multimodal neurostimulation systems and methods | 319 |
| 4 | US20100241195A1 | Apparatus, system and method for selective stimulation | 294 |
| 5 | US20050209513A1 | Collecting sleep quality information via a medical device | 294 |
| 6 | US20050216064A1 | Sensitivity analysis for selecting therapy parameter sets | 274 |
| 7 | US7330760B2 | Collecting posture information to evaluate therapy | 268 |
| 8 | US20050131493A1 | Method and system of remotely controlling electrical pulses provided to nerve tissue(s) by an implanted stimu… | 237 |
| 9 | US7369897B2 | Method and system of remotely controlling electrical pulses provided to nerve tissue(s) by an implanted stimu… | 230 |
| 10 | US20040059395A1 | Patient interactive neurostimulation system and method | 226 |
Citation counts favour older filings simply because they have had longer to accumulate citations inside the corpus; treat this table as a map of influential prior art, not a ranking of current importance.
Each row carries its publication number; clicking a row searches Eureka by that number.
Source: Patsnap Eureka. Citation counts and representative records. Derived from a Patsnap search on Neurostimulation Device Wireless Telemetry Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Run it yourself
Put your own technology through the same analysis
Where to run it
For builders
MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →Insights
What the numbers mean for a filing decision
Three findings shape where a new filer should and should not spend claim drafting effort in this space.
Concentration
79.4%
of 564 records held by top 5
The top of the field is tightly held
Five assignees account for 79.4% of all 564 records in scope, and the top ten reach 89.5%. The leader alone holds 218 records against a fifth-place figure of 15 and a tenth-place figure of 9 — a steep drop-off that leaves the ranked field's remaining 89 companies fighting over a small residual share.
Assignee ranking, 99 companies
Growth
+29%
filings, 2021 to 2024
Investment is still rising, not cooling
Filings grew from 7 in 2021 to 9 in 2024, a 29% increase over that three-year span and the most recent period reliable enough to trust once publication lag is accounted for. Read later years with caution: 2025 and 2026 counts will still fill in as pending applications publish.
Filing trend, 2017-2026
Composition
2.7%
of records tag H04B transmission
Radio-specific claiming is thin
Only 2.7% of records carry an H04B transmission-general class and 1.4% carry H01Q for antennas, versus 8.2% for G06F data processing. Most of the claim volume in this dataset protects the electrotherapy device and its control logic rather than the radio link itself, which is where a first mover in RF-specific claims could still stake ground.
IPC composition, 564 records
Collaboration
10
co-assignee pairs identified
Inventor pairings cluster inside single firms
The strongest co-assignee pairings in the dataset — such as Libbus Imad with Kramer Andrew P, and Libbus Imad with Caparso Anthony V, each appearing on 7 shared records — sit inside the same corporate family rather than across company lines, suggesting internal inventor teams rather than cross-licensing partnerships drive this space.
Co-assignee analysis, 10 pairs
Eureka AI Agent
Looking for what nobody has claimed yet?
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to neurostimulation device wireless telemetry patent landscape, with the prior art for and against each one.
Inventor collaboration patterns
| Assignee | Co-assignee | Shared families |
|---|---|---|
| LIBBUS IMAD | KRAMER ANDREW P | 7 |
| LIBBUS IMAD | CAPARSO ANTHONY V | 7 |
| Boston Scientific Neuromodulation Corporation | MOFFITT MICHAEL A | 5 |
| Boston Scientific Neuromodulation Corporation | BRADLEY KERRY | 5 |
| Cardiac Pacemakers, Inc. | LIBBUS IMAD | 4 |
| LIBBUS IMAD | SWEENEY ROBERT J | 4 |
| LIBBUS IMAD | SIEJKO KRZYSZTOF Z | 4 |
| LIBBUS IMAD | BROCKWAY MARINA V | 4 |
Co-assignee pairs identified in this dataset skew toward repeat inventor teams within the same organisation rather than joint filings between separate companies.
Source: Patsnap Eureka. Co-assignee relationships and derived observations. Derived from a Patsnap search on Neurostimulation Device Wireless Telemetry Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
What's next
Where to take this analysis
The figures above establish the shape of the field. Turning that into a filing or design-around decision means drilling into specific claims and specific assignees.
Map the white space by IPC branch
Cross the thin RF-specific classes (H04B, H01Q) against the dominant A61N electrotherapy claims to find combinations no current assignee has claimed tightly.
Explore white space in EurekaCheck freedom to operate against the leader
With one assignee holding 218 of 564 records, any new filing in this space should be checked against that portfolio's claim scope before drafting begins.
Run a freedom-to-operate checkTrack the 2021-2024 filers
The companies filing during the growth period behind the +29% figure show where competitive attention is currently concentrated.
Monitor active filers in EurekaSource: Patsnap Eureka. Forward-looking reading of the same dataset. Derived from a Patsnap search on Neurostimulation Device Wireless Telemetry Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
FAQ
Common questions about this landscape
The assignee ranking in this dataset is led by a single company holding 218 of the 564 records in scope, with the next four ranked companies combining with the leader to reach 79.4% of all records. The drop-off after the leader is steep — fifth place holds 15 records and tenth place holds 9 — meaning the remainder of the 99 ranked companies each hold a small fraction of the field. This concentration suggests that any new entrant competing on volume alone would be filing into a space where five companies already control most of the granted and pending claim territory.
Yes, based on the most recent reliable data: filings rose from 7 in 2021 to 9 in 2024, a 29% increase, and the field's peak filing year so far was 2020 at 12. Counts for 2025 and 2026 appear lower in the raw data, but that reflects the roughly 18-month lag between filing and publication rather than an actual slowdown, so those years should not yet be read as declining. Treat 2024 as the last year with a trustworthy count.
AU2012352009B2, assigned to Boston Scientific Neuromodulation Corporation, claims a system and method for switching a neurostimulation device between two different electrode-configuration programming modes, where the second configuration is derived from the first in response to the mode switch. It does not claim the wireless transmission mechanism itself; it claims the programming-mode logic that telemetry-based programming systems commonly rely on. Anyone building a programmer that offers multiple stimulation modes with configuration carryover between them should review this claim scope directly rather than relying on this summary.
The IPC composition data points to the radio-transmission side of the field: H04B (transmission, general) appears on only 2.7% of the 564 records and H01Q (antennas) on just 1.4%, far below the 97.2% carried by the core A61N electrotherapy class. That gap means most existing claims protect the stimulation device and its control software rather than the specific wireless link design, leaving RF architecture, antenna placement and link-layer protocol claims comparatively open relative to the device-side claim density.
The United States leads with 260 filings in this dataset, followed by the European Patent Office at 87 and the WIPO PCT route at 68, with Australia at 59 and Germany at 27. This pattern is typical of implantable medical device filings, where applicants secure US protection first, use the PCT route to preserve international options, and then file selectively into Europe and other major device markets such as Germany and Australia.
Answers are grounded in the same dataset. Derived from a Patsnap search on Neurostimulation Device Wireless Telemetry Patent Landscape covering 2015–2026, data cut-off 2026-08-31. Counts reflect published records only and shift as new filings publish.Run this in Eureka MCP
Research Neurostimulation Device Wireless Telemetry Patent Landscape in depth with Eureka
Go past this page: query the whole neurostimulation device wireless telemetry patent landscape corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company's registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.